Molecular Anatomy of 2009 Influenza Virus A (H1N1)
Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of singl...
Gespeichert in:
Veröffentlicht in: | Archives of medical research 2009-11, Vol.40 (8), p.643-654 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 654 |
---|---|
container_issue | 8 |
container_start_page | 643 |
container_title | Archives of medical research |
container_volume | 40 |
creator | Arias, Carlos F Escalera-Zamudio, Marina de los Dolores Soto-Del Río, María Georgina Cobián-Güemes, Ana Isa, Pavel López, Susana |
description | Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia. |
doi_str_mv | 10.1016/j.arcmed.2009.10.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_744619693</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0188440909001969</els_id><sourcerecordid>733255182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</originalsourceid><addsrcrecordid>eNqFkU9P20AQxVcVqITQb1Ah32gPTmd3Z__4ghRFLSCF9lDa68pej6UNjg27MVL66WsTuHBBcxjpzZs30m8Y-8xhwYHrb5tFGf2W6oUAKEZpAWA-sBm3RuYKrTliM-DW5ohQnLDTlDYAYFGbj-xEgAQUis-YuO1b8kNbxmzZlbt-u8_6Jpsis5uuaQfq_pXZ3xCHlC2zL9f8J_96xo6bsk306aXP2Z8f3-9W1_n619XNarnOveK4y7VtuAFDqkZSGlDZymJT6FGvaxS-ENJqlOip0kYWKCuPBiWoSshaKCHn7OKQ-xD7x4HSzm1D8tS2ZUf9kJxB1LzQhXzfKaVQitspEw9OH_uUIjXuIYZtGfeOg5uwuo07YHUTg0kdsY5r5y8HhmqavS69chwNlwcDjUCeAkWXfKDOUx0i-Z2r-_DehbcBvg1d8GV7T3tKm36I3QjbcZeEA_d7eu302bHgGcJ_Q7GZ-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733255182</pqid></control><display><type>article</type><title>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Arias, Carlos F ; Escalera-Zamudio, Marina ; de los Dolores Soto-Del Río, María ; Georgina Cobián-Güemes, Ana ; Isa, Pavel ; López, Susana</creator><creatorcontrib>Arias, Carlos F ; Escalera-Zamudio, Marina ; de los Dolores Soto-Del Río, María ; Georgina Cobián-Güemes, Ana ; Isa, Pavel ; López, Susana</creatorcontrib><description>Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.</description><identifier>ISSN: 0188-4409</identifier><identifier>EISSN: 1873-5487</identifier><identifier>DOI: 10.1016/j.arcmed.2009.10.007</identifier><identifier>PMID: 20304251</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antibodies, Neutralizing - immunology ; Antibodies, Viral - immunology ; Antiviral Agents - therapeutic use ; Biology ; Evolution, Molecular ; Galactose - chemistry ; Galactose - metabolism ; Genes, Viral ; Hemagglutinin Glycoproteins, Influenza Virus - genetics ; Hemagglutinin Glycoproteins, Influenza Virus - immunology ; Humans ; Influenza ; Influenza A virus ; Influenza A Virus, H1N1 Subtype - classification ; Influenza A Virus, H1N1 Subtype - genetics ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H1N1 Subtype - physiology ; Influenza, Human - drug therapy ; Influenza, Human - virology ; Internal Medicine ; Neuraminidase - antagonists & inhibitors ; Neuraminidase - genetics ; Neuraminidase - immunology ; Pandemics ; Pathogenesis ; Phylogeny ; Receptors, Virus - metabolism ; Sialic Acids - chemistry ; Sialic Acids - metabolism ; Viral Proteins - genetics ; Viral Proteins - metabolism ; Viral Tropism ; Virulence ; Virus Replication - physiology</subject><ispartof>Archives of medical research, 2009-11, Vol.40 (8), p.643-654</ispartof><rights>IMSS</rights><rights>2009 IMSS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</citedby><cites>FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.arcmed.2009.10.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20304251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arias, Carlos F</creatorcontrib><creatorcontrib>Escalera-Zamudio, Marina</creatorcontrib><creatorcontrib>de los Dolores Soto-Del Río, María</creatorcontrib><creatorcontrib>Georgina Cobián-Güemes, Ana</creatorcontrib><creatorcontrib>Isa, Pavel</creatorcontrib><creatorcontrib>López, Susana</creatorcontrib><title>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</title><title>Archives of medical research</title><addtitle>Arch Med Res</addtitle><description>Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.</description><subject>Animals</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Viral - immunology</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biology</subject><subject>Evolution, Molecular</subject><subject>Galactose - chemistry</subject><subject>Galactose - metabolism</subject><subject>Genes, Viral</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - genetics</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - immunology</subject><subject>Humans</subject><subject>Influenza</subject><subject>Influenza A virus</subject><subject>Influenza A Virus, H1N1 Subtype - classification</subject><subject>Influenza A Virus, H1N1 Subtype - genetics</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H1N1 Subtype - physiology</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - virology</subject><subject>Internal Medicine</subject><subject>Neuraminidase - antagonists & inhibitors</subject><subject>Neuraminidase - genetics</subject><subject>Neuraminidase - immunology</subject><subject>Pandemics</subject><subject>Pathogenesis</subject><subject>Phylogeny</subject><subject>Receptors, Virus - metabolism</subject><subject>Sialic Acids - chemistry</subject><subject>Sialic Acids - metabolism</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - metabolism</subject><subject>Viral Tropism</subject><subject>Virulence</subject><subject>Virus Replication - physiology</subject><issn>0188-4409</issn><issn>1873-5487</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9P20AQxVcVqITQb1Ah32gPTmd3Z__4ghRFLSCF9lDa68pej6UNjg27MVL66WsTuHBBcxjpzZs30m8Y-8xhwYHrb5tFGf2W6oUAKEZpAWA-sBm3RuYKrTliM-DW5ohQnLDTlDYAYFGbj-xEgAQUis-YuO1b8kNbxmzZlbt-u8_6Jpsis5uuaQfq_pXZ3xCHlC2zL9f8J_96xo6bsk306aXP2Z8f3-9W1_n619XNarnOveK4y7VtuAFDqkZSGlDZymJT6FGvaxS-ENJqlOip0kYWKCuPBiWoSshaKCHn7OKQ-xD7x4HSzm1D8tS2ZUf9kJxB1LzQhXzfKaVQitspEw9OH_uUIjXuIYZtGfeOg5uwuo07YHUTg0kdsY5r5y8HhmqavS69chwNlwcDjUCeAkWXfKDOUx0i-Z2r-_DehbcBvg1d8GV7T3tKm36I3QjbcZeEA_d7eu302bHgGcJ_Q7GZ-Q</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Arias, Carlos F</creator><creator>Escalera-Zamudio, Marina</creator><creator>de los Dolores Soto-Del Río, María</creator><creator>Georgina Cobián-Güemes, Ana</creator><creator>Isa, Pavel</creator><creator>López, Susana</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20091101</creationdate><title>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</title><author>Arias, Carlos F ; Escalera-Zamudio, Marina ; de los Dolores Soto-Del Río, María ; Georgina Cobián-Güemes, Ana ; Isa, Pavel ; López, Susana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Viral - immunology</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biology</topic><topic>Evolution, Molecular</topic><topic>Galactose - chemistry</topic><topic>Galactose - metabolism</topic><topic>Genes, Viral</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - genetics</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - immunology</topic><topic>Humans</topic><topic>Influenza</topic><topic>Influenza A virus</topic><topic>Influenza A Virus, H1N1 Subtype - classification</topic><topic>Influenza A Virus, H1N1 Subtype - genetics</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H1N1 Subtype - physiology</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - virology</topic><topic>Internal Medicine</topic><topic>Neuraminidase - antagonists & inhibitors</topic><topic>Neuraminidase - genetics</topic><topic>Neuraminidase - immunology</topic><topic>Pandemics</topic><topic>Pathogenesis</topic><topic>Phylogeny</topic><topic>Receptors, Virus - metabolism</topic><topic>Sialic Acids - chemistry</topic><topic>Sialic Acids - metabolism</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - metabolism</topic><topic>Viral Tropism</topic><topic>Virulence</topic><topic>Virus Replication - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arias, Carlos F</creatorcontrib><creatorcontrib>Escalera-Zamudio, Marina</creatorcontrib><creatorcontrib>de los Dolores Soto-Del Río, María</creatorcontrib><creatorcontrib>Georgina Cobián-Güemes, Ana</creatorcontrib><creatorcontrib>Isa, Pavel</creatorcontrib><creatorcontrib>López, Susana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Archives of medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arias, Carlos F</au><au>Escalera-Zamudio, Marina</au><au>de los Dolores Soto-Del Río, María</au><au>Georgina Cobián-Güemes, Ana</au><au>Isa, Pavel</au><au>López, Susana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</atitle><jtitle>Archives of medical research</jtitle><addtitle>Arch Med Res</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>40</volume><issue>8</issue><spage>643</spage><epage>654</epage><pages>643-654</pages><issn>0188-4409</issn><eissn>1873-5487</eissn><abstract>Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20304251</pmid><doi>10.1016/j.arcmed.2009.10.007</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0188-4409 |
ispartof | Archives of medical research, 2009-11, Vol.40 (8), p.643-654 |
issn | 0188-4409 1873-5487 |
language | eng |
recordid | cdi_proquest_miscellaneous_744619693 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Antibodies, Neutralizing - immunology Antibodies, Viral - immunology Antiviral Agents - therapeutic use Biology Evolution, Molecular Galactose - chemistry Galactose - metabolism Genes, Viral Hemagglutinin Glycoproteins, Influenza Virus - genetics Hemagglutinin Glycoproteins, Influenza Virus - immunology Humans Influenza Influenza A virus Influenza A Virus, H1N1 Subtype - classification Influenza A Virus, H1N1 Subtype - genetics Influenza A Virus, H1N1 Subtype - immunology Influenza A Virus, H1N1 Subtype - physiology Influenza, Human - drug therapy Influenza, Human - virology Internal Medicine Neuraminidase - antagonists & inhibitors Neuraminidase - genetics Neuraminidase - immunology Pandemics Pathogenesis Phylogeny Receptors, Virus - metabolism Sialic Acids - chemistry Sialic Acids - metabolism Viral Proteins - genetics Viral Proteins - metabolism Viral Tropism Virulence Virus Replication - physiology |
title | Molecular Anatomy of 2009 Influenza Virus A (H1N1) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A50%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Anatomy%20of%202009%20Influenza%20Virus%20A%20(H1N1)&rft.jtitle=Archives%20of%20medical%20research&rft.au=Arias,%20Carlos%20F&rft.date=2009-11-01&rft.volume=40&rft.issue=8&rft.spage=643&rft.epage=654&rft.pages=643-654&rft.issn=0188-4409&rft.eissn=1873-5487&rft_id=info:doi/10.1016/j.arcmed.2009.10.007&rft_dat=%3Cproquest_cross%3E733255182%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733255182&rft_id=info:pmid/20304251&rft_els_id=S0188440909001969&rfr_iscdi=true |